Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diaspective Vision was a German medical technology company focused on hyperspectral and multispectral camera systems for clinical and preclinical applications. The company developed imaging products under the TIVITA brand to provide contact-free, dye-free assessment of tissue perfusion, oxygenation, and related tissue parameters, with applications in wound care, surgery, and endoscopy. Its technology was positioned as a decision-support tool for clinicians and surgeons rather than a drug-development platform. Diaspective Vision also developed the MALYNA endoscopic imaging system combining live imaging, indocyanine green imaging, and multispectral perfusion imaging. In April 2025, KARL STORZ announced the acquisition of Diaspective Vision's intellectual property and selected talent, indicating the standalone company ceased operating independently thereafter.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diaspective Vision.